Tag: data

CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the evaluation of arimoclomol for the treatment of Niemann-Pick Disease Type C (NPC). NPC is an ultra-rare, neurological disease caused by genetic mutations that result in lipid accumulation in cells, leading to visceral, neurological, and psychiatric symptoms. Arimoclomol is the only treatment shown to directly target the underlying pathology of NPC by increasing gene expression for improved lipid clearance. Arimoclomol for the treatment of NPC has been designated as an Orphan Medicinal Product by the EMA. Arimoclomol is marketed in the U.S. under the brand name MIPLYFFA®.

Company Announcement No 63/2025  

To Nasdaq Copenhagen A/S                                28 July 2025
                                        Announcement no. 62/2025

LUXEMBOURG, July 26, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a next-generation blockchain infrastructure protocol, is approaching the final hours of Stage 1 of its presale, offering early adopters programmable Proof-of-Yield (PoY) rewards and ecosystem access at a fixed entry price of $1.00. The project has drawn attention for launching with built-in staking incentives, AI-driven governance, and a collateral-backed stablecoin—all live from day one.

卡爾霍恩，喬治亞州, July 26, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc.（NYSE: MHK）今天宣布 2025 年第二季度淨盈利為 1.47 億美元，每股盈利（「EPS」）為 2.34 美元；調整後淨盈利為 1.73 億美元，調整後每股盈利為 2.77 美元。 2025 年第二季度報告淨銷售額為 28 億美元，與去年相比基本持平，按固定天數和匯率調整後與去年相比下降了 0.8%。 在 2024 年第二季度，公司報告淨銷售額為 28 億美元，淨盈利為 1.57 億美元，每股盈利為 2.46 美元；調整後淨盈利為 1.92 億美元，而調整後每股盈利則為 3.00 美元。